About
Our Leadership
Driving innovation in the treatment of heart and valvular disease.
Overview
How the Collaboratory works
H&VC’s leadership is comprised of top subject matter experts in heart and valvular disease. This multidisciplinary group drives the organization’s decision making through ongoing collaboration and consensus development.
Executive Leadership
The Executive Leadership Team leads the organization’s operational and strategic decisions.
Columbia University Medical Center, New York, NY
Baylor Scott & White Health System, Dallas, TX
Mass General Brigham / Brigham and Women’s Hospital, Boston, MA
Piedmont Heart Cardiothoracic Surgery Atlanta, Atlanta, GA
Duke Clinical Research Institute, Durham, NC
FDA Representation
Through H&VC’s collaborative community model, FDA representatives bring an important regulatory perspective to H&VC discussions and activities.
FDA, Ex Officio
FDA, Ex Officio
Food & Drug Administration
Scientific Council
The Scientific Council serves as a cross-disciplinary voice for identifying challenges and potential solutions for H&VC to address.
University of Michigan, Ann Arbor, MI
Massachusetts General Hospital, Boston, MA
Leipzig Heart Center, Leipzig, Germany
Baylor Scott & White Research Institute, Dallas, TX
Allina Health Minneapolis Heart Institute | Cardiovascular Imaging, Minneapolis, MN
Cardiovascular Research Foundation, New York, NY
American Heart Association, Dallas, TX
Washington University in St. Louis, St. Louis, MO
Cleveland Clinic, Cleveland, OH
Vanderbilt University Medical Center, Nashville, TN
Cedars-Sinai Medical Center, Los Angeles, CA
Québec Heart & Lung Institute, Laval University, Québec City, Canada
Rubrum Advising, Washington, DC
Bern University Hospital, Bern, Switzerland
Georgia Tech & Emory University, Atlanta, GA